NYU College of Dentistry: New Life for a Cancer Drug That Reprograms Pain Pathways to Treat Chronic Pain, in Study by NYU Dentistry’s Dr. Wolfgang Liedtke
Chronic pain associated with nerve injury and chronic bone pain from metastatic cancer are unmet medical needs. A new study led by Wolfgang Liedtke, MD, PhD, an adjunct professor of molecular pathobiology at NYU Dentistry, identified the compound kenpaullone as a promising treatment that could be repurposed to alleviate pain. Kenpaullone functioned as an analgesic in preclinical models of pain in a new study published in Nature Communications.
Read more.